Back to Search
Start Over
Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature.
- Source :
-
Journal of cardiovascular medicine (Hagerstown, Md.) [J Cardiovasc Med (Hagerstown)] 2019 Apr; Vol. 20 (4), pp. 159-168. - Publication Year :
- 2019
-
Abstract
- : Chronic thromboembolic disease (CTED), especially when associated with pulmonary hypertension (CTEPH), is a fearsome and under-diagnosed but potentially curable complication of pulmonary embolism, thanks to recent therapeutic options. Aspecific symptoms and signs make its diagnosis challenging, requiring clinicians to be ready to suspect its presence in patients with dyspnea of unknown origin or persistent symptoms after acute pulmonary embolism. The aim of this review is to provide an update to the general practitioner or the specialist physician on the state of the art regarding the epidemiology, pathophysiology and clinical management of chronic thromboembolic syndromes.
- Subjects :
- Angioplasty, Balloon
Anticoagulants therapeutic use
Antihypertensive Agents therapeutic use
Chronic Disease
Endarterectomy
Hemodynamics
Humans
Predictive Value of Tests
Risk Factors
Treatment Outcome
Hypertension, Pulmonary diagnosis
Hypertension, Pulmonary epidemiology
Hypertension, Pulmonary physiopathology
Hypertension, Pulmonary therapy
Pulmonary Artery diagnostic imaging
Pulmonary Artery drug effects
Pulmonary Artery physiopathology
Pulmonary Artery surgery
Pulmonary Embolism diagnosis
Pulmonary Embolism epidemiology
Pulmonary Embolism physiopathology
Pulmonary Embolism therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1558-2035
- Volume :
- 20
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of cardiovascular medicine (Hagerstown, Md.)
- Publication Type :
- Academic Journal
- Accession number :
- 30720636
- Full Text :
- https://doi.org/10.2459/JCM.0000000000000774